Offer - Urjas Oil for just ₹ 1 X
Cibrim T is a prescription drug, available for use as Drops. Other than this, Cibrim T has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Cibrim T depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Cibrim T are Eye Burning, Eye irritation, Stinging in the Eyes. Besides the aforementioned side effects, there are other adverse effects of Cibrim T as well, which are listed below. Normally, these side effects of Cibrim T are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Cibrim T's effect is Mild during pregnancy and Unknown for lactating mothers. In addition, Cibrim T's effects on the liver, heart and kidney are discussed below in the Cibrim T related warnings section.
Cibrim T is contraindicated in people with pre-existing medical conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other contraindications of Cibrim T have been discussed in the sections ahead.
Drug interactions for Cibrim T have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Cibrim T is considered safe while driving, and is addictive.
Cibrim T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Cibrim T safe for pregnant women?
Pregnant women may get mild side effects from Cibrim T.
Is the use of Cibrim T safe during breastfeeding?
There is no research available on the side effects of Cibrim T in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Cibrim T on the Kidneys?
There may be some adverse effects on kidney after taking Cibrim T. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cibrim T on the Liver?
You may experience side effects on your liver after taking Cibrim T. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cibrim T on the Heart?
There may be an adverse effect on the heart after taking Cibrim T. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Cibrim T should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Cibrim T unless your doctor advises you to do so -
Is this Cibrim T habit forming or addictive?
Cibrim T does not cause addiction.
Interaction between Food and Cibrim T
Taking Cibrim T with food does not cause any problems.
Interaction between Alcohol and Cibrim T
No research has been done on this till date. Therefore, it is not known what the effect of taking Cibrim T with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)